Ministry OF Health OF THE Republic Pharmaceutical Import Profile — Zambia (DGFT 2022–2026)

Name: Ministry OF Health OF THE Republic Pharmaceutical Import Records from India — 4 Products, $4.1M FOB USD (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

Ministry OF Health OF THE Republic — Pharmaceutical Importer Profile (2026) | 4 Products, $4.1M Trade | TransData Nexus

Ministry OF Health OF THE Republic

Pharmaceutical Importer · Zambia · Tuberculosis Medications Focus · $4.1M Total Trade · DGFT Verified

Ministry OF Health OF THE Republic is a pharmaceutical importer based in Zambia with a total trade value of $4.1M across 4 products in 2 therapeutic categories. Based on 82 verified import shipments from Indian Customs (DGFT) records, the company actively imports across multiple product segments. Ministry OF Health OF THE Republic sources from 5 verified Indian suppliers, with Macleods Pharmaceuticals Limited accounting for 75.0% of imports.

Ministry OF Health OF THE Republic — Import Portfolio & Supplier Network

Ministry OF Health OF THE Republic import network — 4 products from Indian suppliers. Source: Indian Customs (DGFT).

Who Are the Verified Indian Suppliers to Ministry OF Health OF THE Republic?

Customs-verified supplier relationships from Indian DGFT records

Supplier	Value	Shipments	Share
Macleods Pharmaceuticals Limited	$1.1M	41	75.0%
Lupin Limited	$313.1K	7	21.4%
Mylan Laboratories Limited

What Formulations Does Ministry OF Health OF THE Republic Import?

Formulation	Value	Ships
Rifampicin 150MG + isoniazid 75MG +	$250.0K	5
Rifampicin 150MG + isoniazid 75MG	$250.0K	5
Rifampicin 150MG / isoniazid 75MG	$100.0K	2
Ethambutol hcl 100MG dispersible	$90.5K	2
Rifampicin 75MG + isoniazid 50MG	$50.0K	1
Rifampicin 150MG isoniazid 75MG pyrazinamide 400MG ethambutol 275MG TAB 3182 x 24x28 s 2138304	$50.0K	1
Ethambutol 100MG dispersibel tablets 2723 packs x 10 x 10 s 272300	$50.0K	1
Rifampicin 75MG / isoniazid 50MG	$50.0K	1
Pretomanid 200MG tablets (26's) (161 packs : 26's bottle)	$50.0K	1
Ethambutol hydrochloride dispersible tablets 100MG (batch no:nee2319c/nee2319d mfg.dt.:aug-2023 exp.dt.:jul-2026	$50.0K	1
Rifampicin 75MG / isoniazid 50MG / pyrazinamide 150MG dispersible tablets (batchno:nru2350a/nru2351a mfg.dt.:oct-2023	$50.0K	1
Rifampin 150 MG & isoniazid 75MG tablets24x28t rifampin and isoniazid tablets (11245 Box)	$50.0K	1
Rifa150+inh75+pzn400+etb275 24x28t gdf rifampicin,isoniazid,pyrazinamide and ethambutol hydrochloride tablets USP(6231	$50.0K	1
Rifa150+inh75+pzn400+etb275 24x28t gdf rifampicin,isoniazid,pyrazinamide and ethambutol hydrochloride tablets USP(4961	$50.0K	1
Rifa150+inh75+pzn400+etb275 24x28t gdf rifampicin,isoniazid,pyrazinamide and ethambutol hydrochloride tablets USP(5846	$50.0K	1

Ministry OF Health OF THE Republic imports 47 distinct pharmaceutical formulations. Showing top 15 by value. For full formulation-level data, contact TransData Nexus.

Import Portfolio — Top 4 by Import Value

#	Product	Category	Value	Ships	Share	Rk
1	Rifampicin	Advanced Antibiotics	$1.8M	36	0.1%	10
2	Isoniazid	Tuberculosis Medications	$1.4M	27	0.1%	12
3	Ethambutol	Tuberculosis Medications	$650.0K	13	0.1%	7
4	Pyrazinamide	Tuberculosis Medications	$300.0K	6	0.0%	4

Ministry OF Health OF THE Republic imports 4 pharmaceutical products across 2 categories into Zambia totaling $4.1M.

Ministry OF Health OF THE Republic — Corporate Profile & Information

Company type, headquarters, distribution network, and industry role

1Company Overview

The Ministry of Health of the Republic of Zambia is the governmental body responsible for overseeing the nation's healthcare system, including the procurement and distribution of medical supplies. As a government entity, it operates without a parent company and plays a pivotal role in ensuring the availability of essential medicines and medical supplies across Zambia. Its operations encompass policy formulation, resource allocation, and the management of healthcare services to meet the needs of the Zambian population.

2Distribution Network

The Ministry of Health's distribution network is extensive, aiming to ensure equitable access to medical supplies throughout Zambia. While specific warehouse locations are not publicly detailed, the ministry collaborates with agencies like the Zambia Medicines and Medical Supplies Agency (ZAMMSA), which operates regional hubs in Mansa, Mpika, Chipata, Choma, Mongu, Kabompo, and Luanshya. These hubs are equipped with modern storage facilities, including cold storage for sensitive products, and are supported by advanced inventory systems and dedicated transportation fleets to facilitate timely delivery to health facilities, even in remote areas. (zammsa.co.zm)

3Industry Role

In Zambia's pharmaceutical supply chain, the Ministry of Health functions as the primary wholesaler and central procurement authority. It is responsible for sourcing, importing, and distributing medical supplies to public health institutions nationwide. This centralization ensures standardized procurement processes and equitable distribution of essential medicines, aligning with the ministry's mandate to provide quality healthcare services to all Zambians.

TransData Nexus Research · Company registries, industry databasesMar 2026

Supplier Relationship Intelligence — Ministry OF Health OF THE Republic

Sourcing concentration, supply chain resilience, and strategic implications

1Sourcing Concentration Analysis

The Ministry of Health's sourcing strategy reveals a significant concentration on a limited number of suppliers. Notably, 75% of the total import value from India is attributed to MACLEODS PHARMACEUTICALS LIMITED, with 41 shipments. This heavy reliance on a single supplier could pose risks related to supply chain disruptions, such as production delays or quality control issues. However, the consistent volume of shipments suggests a stable and ongoing relationship, indicating that the ministry may prioritize reliability and cost-effectiveness in its procurement decisions.

2Supply Chain Resilience

The Ministry of Health's supply chain resilience is closely tied to its dependence on MACLEODS PHARMACEUTICALS LIMITED for a substantial portion of its pharmaceutical imports. While this concentration can lead to efficiencies and cost savings, it also exposes the ministry to potential risks if the supplier faces operational challenges. The presence of additional suppliers, such as LUPIN LIMITED and MYLAN LABORATORIES LIMITED, provides a degree of diversification, but the overall supply chain could benefit from further diversification to enhance resilience. Ensuring that all suppliers adhere to international Good Manufacturing Practices (GMP) and maintaining robust quality assurance protocols are essential steps to mitigate potential risks.

Importing Pharmaceuticals into Zambia — Regulatory Framework

Regulatory authority, GMP requirements, import licensing for Zambia

1Regulatory Authority & Framework

The Zambia Medicines Regulatory Authority (ZAMRA) is the principal body responsible for regulating the pharmaceutical industry in Zambia. Established under the Medicines and Allied Substances Act No. 3 of 2013, ZAMRA oversees the registration, licensing, and monitoring of pharmaceutical products and establishments. The authority ensures that all medicines and medical supplies meet the required standards of quality, safety, and efficacy before they are marketed in Zambia. This regulatory framework is aligned with international standards, including those set by the World Health Organization (WHO), to safeguard public health. (zamra.co.zm)

2Import Licensing & GMP

To import pharmaceutical products into Zambia, companies must obtain a Pharmaceutical License from ZAMRA, which involves demonstrating compliance with Good Manufacturing Practices (GMP). ZAMRA recognizes GMP certifications from reputable international bodies, including the European Union (EU), the World Health Organization (WHO), and the Pharmaceutical Inspection Co-operation Scheme (PIC/S). Importers are also required to secure an import permit for each consignment, ensuring that all imported medicines meet ZAMRA's standards. Additionally, wholesale distributors must obtain authorization from ZAMRA to operate legally within Zambia. (zamra.co.zm)

Ministry OF Health OF THE Republic — Procurement Pattern Analysis

Product strategy, sourcing profile, and market positioning

1Product Strategy

The Ministry of Health's focus on importing tuberculosis (TB) medications and advanced antibiotics aligns with Zambia's public health priorities. TB remains a significant health concern in the country, necessitating a steady supply of effective treatments. The importation of advanced antibiotics addresses the need for specialized medications to combat resistant infections. The market demand for these products is driven by the prevalence of infectious diseases and the ministry's commitment to providing comprehensive healthcare services to the population.

2Sourcing Profile

The Ministry of Health's sourcing strategy emphasizes the procurement of generic drugs, particularly in the therapeutic areas of tuberculosis and advanced antibiotics. This approach is cost-effective and ensures the availability of essential medicines. India's pharmaceutical industry, known for its large-scale production of generics, plays a crucial role in meeting Zambia's procurement needs. The ministry's focus on finished pharmaceutical formulations, rather than raw active pharmaceutical ingredients (APIs), indicates a preference for ready-to-use products that meet international quality standards.

3Market Positioning

Seller's Guide — How to Become a Supplier to Ministry OF Health OF THE Republic

Opportunity assessment, qualifications, and practical approach strategy

1Opportunity Assessment

There is a potential opportunity for new Indian suppliers to enter the Zambian market by offering high-quality, cost-effective generic drugs that meet ZAMRA's regulatory standards. To succeed, suppliers must demonstrate reliability, compliance with international GMP standards, and the capacity to meet large-scale procurement requirements. Additionally, establishing strong relationships with the Ministry of Health and understanding the specific needs of the Zambian healthcare system will be crucial for gaining a competitive edge.

2Requirements & Qualifications

Indian exporters aiming to supply the Ministry of Health must obtain GMP certifications recognized by ZAMRA, such as those from the EU, WHO, or PIC/S. They must also secure a Pharmaceutical License from ZAMRA and comply with all import regulations, including obtaining import permits for each consignment. Products must meet ZAMRA's quality control standards, undergo necessary testing, and adhere to labeling requirements in English. Additionally, exporters should be prepared to participate in Zambia's public procurement processes, which may involve competitive bidding and compliance with the Public Procurement Act.

How to Approach

Frequently Asked Questions — Ministry OF Health OF THE Republic

What products does Ministry OF Health OF THE Republic import from India?

Ministry OF Health OF THE Republic imports 4 pharmaceutical products across 2 categories. Top imports: Rifampicin ($1.8M), Isoniazid ($1.4M), Ethambutol ($650.0K), Pyrazinamide ($300.0K).

Who supplies pharmaceuticals to Ministry OF Health OF THE Republic from India?

Ministry OF Health OF THE Republic sources from 5 verified Indian suppliers. The primary supplier is Macleods Pharmaceuticals Limited (75.0% of imports, $1.1M).

What is Ministry OF Health OF THE Republic's total pharmaceutical import value?

Ministry OF Health OF THE Republic's total pharmaceutical import value from India is $4.1M, based on 82 verified shipments in Indian Customs (DGFT) data.

What therapeutic categories does Ministry OF Health OF THE Republic focus on?

Ministry OF Health OF THE Republic imports across 2 categories. The largest: Tuberculosis Medications (56.1%), Advanced Antibiotics (43.9%).

Get Full Ministry OF Health OF THE Republic Import Intelligence

Access shipment-level details, supplier connections, pricing data, and competitive analysis. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.

Contact for Data Access Request Live Demo

Official References & Regulatory Resources

Verify import regulations and drug registration requirements with the agencies above.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Data Source & Methodology

Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. For current shipment-level data, contact TransData Nexus.